Imperial College London
Portrait Picture

Dr Mark P. Lythgoe

Faculty of Medicine, Department of Surgery & Cancer

Research Postgraduate
 
 
 
//

Contact

 

m.lythgoe

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Lythgoe:2021:10.1038/s41571-021-00559-0,
author = {Lythgoe, MP and Prasad, V},
doi = {10.1038/s41571-021-00559-0},
journal = {Nature Reviews Clinical Oncology},
pages = {745--746},
title = {The FDA's latest move to expand eligibility for oncology trials - a double-edged sword?},
url = {http://dx.doi.org/10.1038/s41571-021-00559-0},
volume = {18},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Lythgoe,MP
AU  - Prasad,V
DO  - 10.1038/s41571-021-00559-0
EP  - 746
PY  - 2021///
SN  - 1759-4774
SP  - 745
TI  - The FDA's latest move to expand eligibility for oncology trials - a double-edged sword?
T2  - Nature Reviews Clinical Oncology
UR  - http://dx.doi.org/10.1038/s41571-021-00559-0
UR  - https://www.ncbi.nlm.nih.gov/pubmed/34535789
UR  - https://www.nature.com/articles/s41571-021-00559-0
UR  - http://hdl.handle.net/10044/1/91762
VL  - 18
ER  -
Download